U.S. Stock News

Genworth Financial reported second quarter 2025 results, noting net income of US$51 million, a decrease from US$76 million in the prior year's quarter, and announced that it completed repurchasing over 108 million shares for US$629.96 million since launching its buyback in May 2022. This substantial buyback represents nearly a quarter of outstanding shares, highlighting the company's commitment to returning capital to shareholders during a period of lower net earnings. We'll examine how...

Earlier this month, ACI Worldwide reported second quarter 2025 results with revenue of US$401.26 million, exceeding analyst expectations, and raised its full-year 2025 revenue guidance to a range of US$1.71 billion to US$1.74 billion following strong year-to-date growth. Alongside robust financials, ACI Worldwide completed a significant share repurchase, retired millions of shares, and advanced its next-generation payments platform to capitalize on digital payments trends and regulatory...

On August 7, 2025, UWM Holdings Corporation announced its second quarter results, reporting revenue of US$758.7 million and net income of US$22.91 million, both higher than the prior year, along with third quarter guidance of production between US$33 billion and US$40 billion and a gain margin of 100 to 125 basis points; the company also affirmed a US$0.10 per share cash dividend for October 2025. The combination of stronger year-over-year earnings, forward-looking operational guidance, and...

During the second quarter of 2025, Avis Budget Group completed its long-standing share repurchase program, buying back a total of 83,626,152 shares for US$7.36 billion, although no shares were repurchased between April and June 2025. Meanwhile, Avis continued to contend with operational headwinds such as vehicle recalls and delivery delays, while also expanding premium services with the rollout of Avis First and deepening its partnership with Waymo in autonomous vehicle fleet...

Janux Therapeutics recently announced the dosing of the first patient in its TRACTr collaboration program with Merck, triggering a US$10 million milestone payment and highlighting clinical progress across its pipeline, including Phase 1 trials for JANX007 and JANX008. This milestone underscores the continued momentum in Janux’s innovative bispecific product pipeline for oncology and potential therapies for autoimmune diseases. We'll explore how clinical progress and milestone payments from...

Astec Industries announced its second quarter 2025 results, reporting US$330.3 million in sales and a swing to net income of US$16.7 million from a net loss in the prior year, alongside a new shelf registration for over US$52.8 million in common stock. Despite a year-over-year drop in quarterly sales, the company's turnaround to profitability suggests improved cost control or operational efficiency played a crucial role this period. We’ll examine how Astec Industries’ return to profit after...

In July 2025, EMCOR Group reported strong earnings for the second quarter and first half, with sales rising to US$4.30 billion and US$8.17 billion respectively, alongside increased net income and earnings per share compared to the prior year. The company also raised its full-year 2025 revenue guidance and completed substantial share repurchases, signaling management's confidence in ongoing business momentum and operational performance. We'll explore how EMCOR Group’s raised revenue outlook...

In recent days, ABM Industries has seen elevated options market activity, with high implied volatility for the October 17, 2025 $22.50 call, as well as analysts slightly raising earnings estimates and maintaining a positive outlook. This combination of heightened options activity and improved analyst sentiment suggests that investors anticipate a significant move or event affecting the company’s prospects. We'll consider how the increased options volatility and positive analyst revisions...

Smurfit Westrock reported second quarter 2025 earnings, showing sales of US$7.94 billion and a net loss of US$28 million, with the board also affirming a quarterly dividend of US$0.4308 per share. The sharp jump in sales reflects the impact of the recent merger, while enduring a quarterly loss suggests integration and cost challenges were still present during the period. We'll explore how the company's decision to maintain its dividend amid a quarterly net loss influences the longer-term...

Marqeta, Inc. recently reported second quarter 2025 results, with quarterly sales reaching US$150.39 million, up from US$125.27 million a year earlier, while moving from a net income of US$119.11 million last year to a small net loss of US$647,000. The company also raised its full-year 2025 revenue growth outlook following strong transaction volume growth across core lending and expense management verticals, despite some macroeconomic uncertainties. We’ll now explore how Marqeta’s upgraded...

In the past week, Quaker Chemical Corporation reported second quarter results, posting sales of US$483.4 million and a net loss of US$66.58 million, primarily due to an US$88.8 million goodwill impairment charge in its EMEA segment. Despite a dividend increase and completing a share repurchase program, Quaker Chemical's results reflected ongoing economic headwinds and a significant decline in profitability compared to last year. We'll explore how the goodwill impairment and weak earnings...

Rigetti Computing reported its Q2 2025 results on August 12, revealing quarterly sales of US$1.8 million and a net loss of US$39.65 million, both weaker than the prior year. While financial performance faced pressure, management emphasized continued advances in quantum hardware and developing partnerships as key areas of long-term focus. We’ll examine how Rigetti’s ongoing investments in quantum technology innovation shape the company’s investment narrative following these quarterly...

Capri Holdings Limited recently reported its first quarter results for fiscal 2026, posting net income of US$53 million on sales of US$797 million, a return to profitability compared to a loss a year ago, and issued new revenue and earnings guidance for the next quarter and full year. Shortly after, Capri Holdings also filed a US$52.1 million shelf registration for 2.5 million ordinary shares in an ESOP-related offering, suggesting a focus on employee engagement and potential changes to its...

Topgolf Callaway Brands Corp. recently reported second quarter 2025 results showing a decline in revenue to US$1.11 billion and net income to US$20.3 million, and lowered its full-year 2025 consolidated net revenue guidance to a range between US$3.80 billion and US$3.92 billion from its previous projection. The company also announced the upcoming resignation of CEO Artie Starrs, who will remain with the business until September 2025 to assist with the leadership transition. With the lowered...

SiTime Corporation recently reported its second quarter results with sales of US$69.49 million and a reduced net loss of US$20.18 million compared to the previous year, while also issuing third quarter revenue guidance of US$77 million to US$79 million. A key insight is that the company not only delivered substantial year-over-year revenue growth, but also indicated an expectation of further improvement in the upcoming quarter, signaling continued momentum in its business performance. We'll...

Cabot Corporation recently reported third-quarter fiscal 2025 earnings above analyst expectations, with adjusted earnings per share reaching US$1.90 despite a 9.2% year-over-year decline in net sales to US$923 million. In addition to reaffirming its fiscal 2025 guidance, Cabot has outlined plans for acquisitions and investments targeting growth areas such as batteries and conductive materials, while highlighting robust cash flow and a disciplined capital allocation approach. We'll explore...

Intellia Therapeutics recently announced that Dr. David Lebwohl, its Executive Vice President and Chief Medical Officer, will retire effective August 7, 2026, and also reported second quarter 2025 financial results showing a reduced net loss year-over-year. The decrease in net loss, both for the quarter and the first half of the year, stands out as a significant shift in the company’s financial trajectory. We’ll explore how the improved quarterly loss positions Intellia Therapeutics within...

Earlier this month, Rayonier Inc. reported second quarter 2025 earnings showing a significant increase in net income, driven by the completed sale of its New Zealand joint venture for US$710 million and a robust performance in Pacific Northwest Timber and Real Estate segments. This asset sale has allowed Rayonier to focus on its core U.S. operations, strengthen its balance sheet, and pursue capital returns to shareholders through buybacks and potential debt reduction. We'll examine how...

EchoStar Corporation recently reported its second quarter 2025 financial results, revealing revenue of US$3.72 billion and a net loss of US$306.13 million, both down from the same period last year. These results show EchoStar's losses per share and revenue declines have accelerated, increasing pressure on the company's ongoing turnaround efforts. Given these wider losses and reduced revenues, we'll examine how this may impact EchoStar's investment narrative and outlook. The end of cancer?...

In recent announcements, 180 Life Sciences Corp. reported the completion of very large private placements, raising over US$425 million through common share and pre-funded warrant offerings, alongside the issuance of US$156.25 million in convertible notes to an institutional investor. A simultaneous overhaul in board composition introduced directors with extensive experience in finance, energy, and capital markets, signaling a potential evolution in the company’s operational focus and market...

Roivant Sciences recently reported first quarter 2025 earnings, revealing sales of US$2.17 million and a net loss of US$223.36 million compared to net income a year earlier, while also updating its ongoing share repurchase activities. The company completed buybacks totaling 148.63 million shares and announced plans for an additional US$500 million repurchase, signaling ongoing shareholder return efforts despite weaker financial results. We'll examine how Roivant's substantial net loss...

On August 3, 2025, Atlas Energy Solutions Inc. declared a quarterly dividend of US$0.25 per share, totaling approximately US$30.9 million, payable on August 21, 2025 to shareholders of record as of August 14, 2025, and also reported half-year results with sales of US$15.99 million, revenue of US$288.68 million, and a net loss of US$5.56 million. Despite posting a net loss for the half year, Atlas Energy Solutions continued to affirm its dividend, an outcome that can signal the company's...

Core Natural Resources, Inc. recently reported second quarter 2025 results, highlighting sales of US$1.10 billion, more than double the prior year’s figure, yet posted a net loss of US$36.56 million compared to net income a year earlier. This contrast between strong top-line growth and a swing to a substantial loss highlights ongoing operational and profitability challenges for the company. We'll explore how Core's sharp year-over-year decline in profitability, despite surging sales,...

O-I Glass, Inc. recently filed a shelf registration with the SEC covering the potential offering of 9,000,000 shares of common stock, amounting to US$114.03 million, in connection with its Employee Stock Ownership Plan (ESOP). This filing signals O-I Glass's intention to potentially issue new shares for its ESOP, an action that can impact investor perceptions by raising questions about future share supply and employee engagement initiatives. We'll examine how the ESOP-focused equity offering...